An accurate homogenized tissue phantom for broad spectrum autofluorescence studies: A tool for optimizing quantum dot-based contrast agents

Progress in Biomedical Optics and Imaging - Proceedings of SPIE

Volumn 6870, Issue , 2008, Pages

  Roy, Mathieu ^a   Wilson, Brian C ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b PRINCESS MARGARET HOSPITAL   (Canada)

Author keywords

Autofluorescence; Contrast; Extrapolation; Homogenized tissue; Microfluidics; Optical phantom; Optical properties; Optimization; Quantum dots; Signal to background ratio

Indexed keywords

(1 1 0) SURFACE; (P ,P ,T) MEASUREMENTS; AUTOFLUORESCENCE (AF); BACKGROUND RATIO; BIOCONJUGATES; BROAD SPECTRUM; CONCENTRATION (COMPOSITION); CONTRAST AGENT (CA); CONTRAST OPTIMIZATION; EARLY CANCER DETECTION; FLUORESCENT CONTRAST AGENTS; IN-VIVO; NON LINEAR EFFECTS; OPTICAL (PET) (OPET); OPTICAL MEASUREMENTS; OPTICAL THICKNESS; PERFORMANCE VALIDATION; QUANTUM DOT (CO); SILICA CAPILLARY; TISSUE AUTOFLUORESCENCE; TISSUE HOMOGENATES; TISSUE PHANTOMS; VISIBLE SPECTRUM (VIS);

ABSORPTION; ABSORPTION SPECTROSCOPY; AEROSPACE APPLICATIONS; ARCHITECTURAL DESIGN; CADMIUM COMPOUNDS; CURVE FITTING; FLUORESCENCE; IMAGING TECHNIQUES; INDUSTRIAL MANAGEMENT; INTEGER PROGRAMMING; LIGHT EMISSION; LUMINESCENCE; MATHEMATICAL MODELS; MEASUREMENTS; MULTITASKING; OPTICAL DESIGN; OPTICAL VARIABLES MEASUREMENT; OPTICAL WAVEGUIDES; OPTIMIZATION; QUANTUM ELECTRONICS; SEMICONDUCTOR QUANTUM DOTS; SIGNAL PROCESSING; SILICA; SILICATE MINERALS; SILICON COMPOUNDS; STABILIZERS (AGENTS); ZINC SULFIDE;

TISSUE;

EID: 42149188812     PISSN: 16057422     EISSN: None     Source Type: Conference Proceeding    
DOI: 10.1117/12.764639     Document Type: Conference Paper

References (13)

1. Dacosta et al., New optical technologies for earlier endoscopie diagnosis ofpremalignant gastrointestinal lesions, J. Gastroenterology Hepatol., 17 Suppl: S85-104 (2002)
2. DaCosta et al., Optical techniques for the endoscopie detection of dysplastic colonic lesions, Current Opinion in Gastroenterology, 21:70-79 (2005)
3. Ferrari, Cancer Nanotechnology: Opportunities and challenges, Nature Reviews Cancer, 5:161-171 (2005)
4. Chan et al., Luminescent quantum dots for multiplexed biological detection and imaging, Current Opinion in Biotechnology, 13: 40-6 (2002)
5. Derfus et al., Probing the Cytotoxicity of Semiconductor Quantum Dots, Nano Letters, 4, 11-18 (2004)
6. Fischer et al., Parmacokinetics of Nanoscale Quantum Dots: In vivo Distribution, Sequestration, and Clearance in the Rat, Advanced Functional Materials, 16:1299-1305 (2006)
7. Medintz et al., Quantum dot bioconjugates for imaging, labelling and sensing, Nature Materials, 4:435-446 (2005)
8. Lim et al., Selection of Quantum Dot Wavelengths for Biomedical Assays and Imaging, MoI. Imaging, 2:50-64 (2003)
9. Roy et al., Quantum dots as contrast agents for endoscopy: mathematical modeling and experimental validation of the optimal excitation wavelength, Proc. SPIE, 6448-32 (2007)
10. Jiang et al., Design and Characterization of Lysine Cross-Linked Mercapto-Acid Biocompatible Quantum Dots, Chemistry of Materials, 18, 872-878 (2006)
11. Dam et al., Multiple polynomial regression method for determination of biomedical optical properties from integrating sphere measurements, Applied Optics, 39: 1202-1209 (2000)
12. Staveren et al., Light scattering in Intralipid-10% in the wavelength range of 400-1100 nanometers, Applied Optics, 30:4507-4514 (1991)
13. Müller et al., Intrinsic fluorescence spectroscopy in turbid media: disentangling effects of scattering and absorption, Applied Optics, 40: 4633-4646 (2001)